AI isn't new, but that doesn't mean it's easy to implement. To help build understanding -- about creating AI systems & the benefits pharma can reap when using them -- Intouch VP of innovation, Abid Rahman will lead a masterclass during the upcoming AHIMA2020 virtual conference.
In part two of this series on creating successful chatbot interactions, we talk about how to elevate your customers’ experience even further, with personalized dialog, entertainment at the right time, and the utmost attention to details.
Robots are no longer the stuff of science fiction, and as more brands adopt conversational AI, some key considerations can enhance the chatbot user experience. In part one of this two-part series, we’ll talk about chatbots, human users, and live agents, and offer several tips for success.
More and more, the principles of anthropology are being used in business -- but how can the study of human cultures help pharma marketers connect with patients and make sure they're getting the treatments they need? Read on to find out.
Today, the voices of influencers are vital. They can be gatekeepers to their audiences and authenticators of brand messaging, serving as extended voices of a brand. So how can pharma work well with health influencers, and to do so with expert precision? Find out here!
Facebook's new feature for businesses, called Limited Data Use, restricts how it stores and processes data belonging to California residents. Find out what pharma marketers need to know to comply with LDU.
Craft matters, and it is the next frontier in our industry. Susan Perlbachs, Intouch Group's new CCO, talks about what it takes to create healthcare marketing that can stand up and hold its own next to the most beautiful and inspirational ads anywhere -- in any category.
Many brand teams follow the same planning process year after year, but during the pandemic, the parameters have shifted dramatically. How can marketers plan for the future when there are so many unknowns? Read on to find out.
In this POV, market access gurus Mike Motto, Glen Davis, and Peter Weissberg, discuss recent Trump administration action on drug pricing, the likelihood of further action before the 2020 election, and how pharma manufacturers can provide affordable options for more Americans.
As the demand for more privacy protections continues, the ad industry moves to create new standards that protect digital advertising practices, including targeting and messaging, while also maintaining consumer privacy.
